{
  "question_stem": {
    "en": "Appropriate treatment is begun, and the patient reports significant symptom improvement. However, she now has abdominal cramping, nausea, sweating, and diarrhea. ",
    "zh": "开始适当治疗后，患者报告症状明显改善。然而，她现在出现腹部绞痛、恶心、出汗和腹泻。"
  },
  "question": {
    "en": "Which of the following agents can be used to effectively control these new symptoms?",
    "zh": "以下哪种药物可用于有效控制这些新出现的症状？"
  },
  "options": {
    "A": {
      "en": "Fluoxetine",
      "zh": "氟西汀"
    },
    "B": {
      "en": "Glycopyrrolate",
      "zh": "格隆溴铵"
    },
    "C": {
      "en": "Pilocarpine",
      "zh": "毛果芸香碱"
    },
    "D": {
      "en": "Prazosin",
      "zh": "哌唑嗪"
    },
    "E": {
      "en": "Propranolol",
      "zh": "普萘洛尔"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "First-line treatment of myasthenia gravis (MG) is a cholinesterase inhibitor, such as pyridostigmine, which inhibits the degradation of acetylcholine in the neuromuscular junction, prolonging the action of acetylcholine. Because it increases the concentration of acetylcholine, it increases the stimulation of both nicotinic receptors, which are impacted in MG, and muscarinic receptors, which are normal in MG. Therefore, acetylcholinesterase inhibitors improve skeletal muscle weakness but can cause muscarinic overstimulation of the smooth muscles and excessive glandular secretions (eg, diarrhea, diaphoresis, abdominal cramping, emesis).\n\nSelective muscarinic antagonists (eg, glycopyrrolate, hyoscyamine, propantheline) can be used to reduce the adverse effects of cholinesterase inhibitors in sites where acetylcholinesterase action is mediated by muscarinic receptors (ie, gastrointestinal tract). Because of their selectivity, these drugs improve adverse effects without affecting the action of cholinesterase inhibitors on skeletal muscle.\n\n(Choice A) Fluoxetine is a selective serotonin reuptake inhibitor used primarily in the treatment of depression. It acts in a fashion similar to the cholinesterase inhibitors in that it prolongs the activity of a neurotransmitter on its target tissue. However, fluoxetine is otherwise unrelated to cholinesterase inhibitors or their effects.\n\n(Choice C) Pilocarpine is a nonselective muscarinic receptor agonist often used to improve symptoms of dry mouth (eg, Sjögren disease). Use of this agent would worsen this patient's side effects.\n\n(Choices D and E) Prazosin is an alpha-1 adrenergic antagonist and propranolol is a beta-adrenergic antagonist; these agents can be used to treat hypertension. Use of either agent does not prevent the adverse effects of a cholinesterase inhibitor.\n\nEducational objective:\nThe treatment of myasthenia gravis involves the use of acetylcholinesterase inhibitors. Adverse effects are related to muscarinic overstimulation, which can be ameliorated by the use of an antimuscarinic agent such as glycopyrrolate.",
    "zh": "重症肌无力 (MG) 的一线治疗是胆碱酯酶抑制剂，如吡啶斯的明，它抑制乙酰胆碱在神经肌肉接头的降解，延长乙酰胆碱的作用。因为它增加了乙酰胆碱的浓度，所以它增加了对烟碱受体（在 MG 中受到影响）和毒蕈碱受体（在 MG 中正常）的刺激。因此，乙酰胆碱酯酶抑制剂可改善骨骼肌无力，但可引起平滑肌的毒蕈碱过度刺激和过多的腺体分泌（如腹泻、出汗、腹部绞痛、呕吐）。\n\n选择性毒蕈碱受体拮抗剂（如格隆溴铵、天仙子胺、丙胺太林）可用于减少胆碱酯酶抑制剂在乙酰胆碱酯酶作用由毒蕈碱受体介导的部位（即胃肠道）的不良反应。由于它们的选择性，这些药物可改善不良反应，而不会影响胆碱酯酶抑制剂对骨骼肌的作用。\n\n（选项 A）氟西汀是一种选择性 5-羟色胺再摄取抑制剂，主要用于治疗抑郁症。它的作用方式与胆碱酯酶抑制剂相似，因为它延长了神经递质在其靶组织上的活性。然而，氟西汀与胆碱酯酶抑制剂或它们的作用无关。\n\n（选项 C）毛果芸香碱是一种非选择性毒蕈碱受体激动剂，常用于改善口干症状（如干燥综合征）。使用这种药物会加重患者的副作用。\n\n（选项 D 和 E）哌唑嗪是一种 α-1 肾上腺素能受体拮抗剂，普萘洛尔是一种 β-肾上腺素能受体拮抗剂；这些药物可用于治疗高血压。使用这两种药物中的任何一种都不能预防胆碱酯酶抑制剂的不良反应。\n\n教学目标：\n重症肌无力的治疗涉及使用乙酰胆碱酯酶抑制剂。不良反应与毒蕈碱过度刺激有关，可通过使用抗毒蕈碱药物（如格隆溴铵）来改善。"
  },
  "summary": {
    "en": "This question tests knowledge of the treatment of myasthenia gravis and the side effects of cholinesterase inhibitors. It also tests the ability to recognize and manage muscarinic overstimulation caused by these medications.\n\nThe best approach is to understand the mechanism of action of cholinesterase inhibitors and their potential side effects. Recognizing the symptoms of muscarinic overstimulation and knowing the appropriate treatment with a selective muscarinic antagonist is key to answering this question correctly.",
    "zh": "此题考察了对重症肌无力治疗的知识以及胆碱酯酶抑制剂的副作用。它还考察了识别和管理这些药物引起的毒蕈碱过度刺激的能力。\n\n最好的方法是了解胆碱酯酶抑制剂的作用机制及其潜在的副作用。识别毒蕈碱过度刺激的症状并了解使用选择性毒蕈碱受体拮抗剂的适当治疗是正确回答此问题的关键。"
  },
  "tags": "Myasthenia gravis; Cholinesterase inhibitors; Muscarinic receptors; Glycopyrrolate; Pharmacology; Neurology",
  "category": "Neuro",
  "question_id": "2062",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Neuro 23\\2062",
  "extracted_at": "2025-11-05T15:32:27.441136",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:24:41.887797",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}